Cetera Investment Advisers »

Celldex Therapeutics shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $269k 9.9k 27.16
2025-09-30 $256k 9.9k 25.87

More positions owned by Cetera Investment Advisers

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Cetera Investment Advisers

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Commodore Capital
Deep Track Capital
Braidwell
Point72 Asset Management
Eventide Asset Management
Geode Capital Management
Eversept Partners
Novo A/S

View all funds holding Celldex Therapeutics